- Entry
- $36.53
- Final
- $47.41 +29.8%
- Target
- —
- Score
- -1.00
NVO's key patent on semaglutide, the active ingredient in Ozempic and Wegovy expired in India on March 20 and cheaper copies are already in market for ~14 dollars. The patent will soon expire in China and amny other countries as well.
— ORIGINAL POST ·
Patent for Semaglutide, the active ingredient in Ozempic and Wegovy expired in India on March 20
· r/wallstreetbets
· Mar 23, 2026